Market News AIOpen the app

AUTL stock news · Autolus Therapeutics

Stories about Autolus Therapeutics (AUTL) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for AUTL

Follow Autolus Therapeutics (AUTL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for AUTL
Free on the App Store and Google Play, or on the web.
  1. Nov 4, 2026, 12:59 PM ET · Paperwork

    Autolus Therapeutics shared online summaries for the ASH Annual Meeting, showing data on its T cell therapy candidates.

    Good for AUTL

    Autolus announced online publication of abstracts for its December 12–15 ASH meeting. Early ALARIC patients had complete blood responses, an encouraging sign for its therapy.

  2. Aug 11, 2026, 7:42 AM ET · Market

    Autolus Therapeutics plc discloses operational results and financial status (AUTL).

    Neutral

    Autolus Therapeutics has filed a Form 8-K detailing its results of operations and financial condition, which is crucial for investors to assess the company's performance and future outlook. The immediate nature of this filing suggests that it could lead to significant trading activity as investors react to the new information.